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The title compound, C21H24O6, is the reduced form of
curcumin, and exhibits important cosmoceutical properties.
The molecule is non-planar and the benzene rings positioned
at the ends of the heptane chain are orthogonally placed, with
a dihedral angle of 84.09 (7) between them. The molecular
geometry and H-atom locations reveal that the `heptane-3,5-
dione' moiety exists in the keto±enol form, with the hydroxy H
atom disordered over two adjacent sites. The packing of the
molecules in the lattice is directed by strong OÐH  O
intermolecular hydrogen bonds, which generate two-dimen-
sional sheets. These sheets are linked by CÐH  O hydrogen
bonds and weak CÐH   interactions to develop a three-
dimensional network.
Comment
Tetrahydrocurcuminoids, such as the title compound, (I), are
derived from curcuminoids, such as (II), and may be extracted
from the roots of Curcuma longa, commonly called turmeric
root (Govindarajan, 1980). Tetrahydrocurcuminoids are
colourless, unlike the yellow curcuminoids. They may there-
fore be used in colour-free foods and cosmetic products, which
currently employ conventional synthetic antioxidants such as
butylated hydroxytoluene (BHT). An antioxidant used in a
cosmetic application should have the capability of ef®ciently
quenching any radicals on the surface of the skin. In this
context, compound (I) displays a superior free-radical
scavenging ability and also exhibits antioxidant, anti-in¯am-
matory and skin-lightening actions (Sugiyama et al., 1996;
Srihari Rao et al., 1982) and anticancer activity (Huang et al.,
1995). It is thought that the p-hydroxy functional groups in (I)
are responsible for the antioxidant and chemopreventive
action of the compound (Rao et al., 1995; Halliwell &
Gutteridge, 1985). We have established the crystal structure of
(I) with the intention that it will assist in pharmocological
studies of the compound.
Electron delocalization and intramolecular hydrogen
bonding in the keto-enol moiety ÐCOÐHC CÐOH have
been studied in a number of molecules (Semmingsen, 1976)
and in curcuminoid structures (Mostad, 1994; Arrieta et al.,
2000; Tonnesen et al., 1982). Of the possible tautomeric forms,
it appears that, in the crystal phase, -diketones prefer the cis-
enol arrangement stabilized by a strong intramolecular
hydrogen bond.
A view of (I) with the labelling scheme is shown in Fig. 1 and
the principal geometry details of the keto±enol function are
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Figure 1
The structure of (I), showing the atom-numbering scheme and 30%
probability displacement ellipsoids. H atoms are shown as small spheres
of arbitrary radii.
Figure 2
A difference map in the plane of the keto±enol system, showing the
hydroxy H-atom disorder at O3 and O5 and the single H atom at C4.
Contours are drawn at 0.05 e AÊ ÿ3.
given in Table 1. A difference map (Fig. 2) clearly established
that there is only one H atom at C4 and that the `dione' adopts
the expected keto±enol form, but with the hydroxy H atom
essentially equally disordered between atoms O3 and O5
[respective hydroxy-atom occupancies = 0.54 (4) and 0.46 (4)],
corresponding to structures (Ia) and (Ib) (see scheme below).
The key bond lengths (Table 1) are entirely consistent with
this disorder model and with strong intramolecular O3Ð
H  O5 and O5ÐH  O3 hydrogen bonds (Table 2). The
keto±enol moiety C3±C5/O3/O5 is planar [deviations in the
range ÿ0.012 (1) to 0.015 (1) AÊ ]. The aromatic rings C11±C16
and C71±C76 form interplanar angles of 88.4 (1) and 9.9 (1),
respectively, with the keto±enol plane, and an angle of
88.4 (1) with one another.
The unit-occupancy hydroxy groups O14ÐH14 and O74Ð
H74 both take part in strong bifurcated intra- and inter-
molecular OÐH  O hydrogen bonds which, together with a
CÐH  O hydrogen bond (Table 2), serve to link the mol-
ecules into sheets in the (110) plane entirely by simple
translation, as shown in Fig. 3. In this way, large R55(42) rings
(Bernstein et al., 1995) are developed, utilizing ®ve OÐH  O
hydrogen bonds.
The packing of (I) is further stabilized into a three-dimen-
sional network by CÐH  O and CÐH   intermolecular
interactions, which serve to link inversion-related sheets. Fig. 4
shows an R22(30) ring generated by pairs of inversion-related
C12ÐH12  O74(2 ÿ x, 1 ÿ y, 1 ÿ z) hydrogen bonds (see
Table 2). The hydrogen-bonded sheets are further linked by
weak CÐH   interactions between inversion- and transla-
tion-related molecules, as shown in Fig. 5 (details are given in
Table 2). A combination of aromatic CÐH   and CÐH  O
interactions generate different packing motifs with altered
molecular conformations. This may have a signi®cant impact
on the biological activity of the compound.
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Figure 3
A packing diagram for (I), showing the hydrogen-bonded sheet of
molecules. Atoms labelled with an asterisk (*), dollar sign ($), hash (#) or
`at' symbol (@) are at the symmetry positions (1 + x, 1 + y, 1 + z), (x, y,
z ÿ 1), (x, y, 1 + z) and (x, 1 + y, 1 + z), respectively.
Figure 4
A diagram showing pairs of molecules about the inversion centre at
(1, 12,
1
2), linked to form a dimer via CÐH  O interactions. Atoms labelled
with an asterisk (*) are at the symmetry position (2 ÿ x, 1 ÿ y, 1 ÿ z).
Figure 5
A diagram showing the development of a chain of molecules in the c
direction via weak CÐH   interactions, with links generated by a
combination of inversion and translation. Atoms labelled with an asterisk
(*), dollar sign ($) or hash (#) are at the symmetry positions (1 ÿ x, 1 ÿ y,
ÿz), (x, y, 1 + z) and (1 ÿ x, 1 ÿ y, 1 ÿ z), respectively.
Experimental
Curcumin, (II), was converted to tetrahydrocurcumin, (I), by
hydrogenation, with PtO2 as catalyst, according to the method of
Uehara et al. (1987). Single crystals of (I) were grown by slow
evaporation of a solution in methanol.
Crystal data
C21H24O6
Mr = 372.40
Triclinic, P1
a = 7.981 (3) AÊ
b = 11.388 (3) AÊ
c = 12.497 (3) AÊ
 = 117.065 (3)
 = 100.394 (10)
 = 94.856 (3)
V = 976.7 (5) AÊ 3
Z = 2
Dx = 1.266 Mg m
ÿ3
Mo K radiation
Cell parameters from 400
re¯ections
 = 2.6±20.9
 = 0.09 mmÿ1
T = 293 K
Prism, off-white
0.40  0.35  0.30 mm
Data collection
Bruker SMART APEX CCD area-
detector diffractometer
’ and ! scans
Absorption correction: multi-scan
(SADABS; Sheldrick, 1996)
Tmin = 0.893, Tmax = 0.981
10 125 measured re¯ections
3933 independent re¯ections
3244 re¯ections with I > 2(I)
Rint = 0.014
max = 27.1

h = ÿ9! 9
k = ÿ14! 14
l = ÿ15! 15
Re®nement
Re®nement on F 2
R[F 2 > 2(F 2)] = 0.055
wR(F 2) = 0.171
S = 1.06
3933 re¯ections
251 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0943P)2
+ 0.1978P]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.30 e AÊ
ÿ3
min = ÿ0.36 e AÊ ÿ3
All H atoms were visible in difference maps. It was clear that there
was H-atom disorder at the O3 and O5 sites, and this was allowed for
by re®nement of linked occupancy parameters for atoms H3 and H5
[®nal values = 0.54 (4) and 0.46 (4)]. All H atoms were treated as
riding, with CÐH = 0.93 AÊ for aromatic, 0.97 AÊ for CH2 and 0.96 AÊ
for CH3 H atoms, and with Uiso(H) = 1.5Ueq(C) for methyl and
1.2Ueq(C) for all other H atoms.
Data collection: SMART (Bruker, 1998); cell re®nement: SMART;
data reduction: SAINT (Bruker, 1998); program(s) used to solve
structure: SIR92 (Altomare et al., 1993); program(s) used to re®ne
structure: SHELXL97 (Sheldrick, 1997); molecular graphics:
PLATON (Spek, 2003) and ORTEP-3 (Farrugia, 1977); software
used to prepare material for publication: PLATON.
CRG thanks the UGC±FIP for a Teacher Fellowship. The
authors thank the Department of Science and Technology,
India, for data collection on the CCD facility set up under the
IRPHA DST program. NBS thanks the UGC±DRS program.
Supplementary data for this paper are available from the IUCr electronic
archives (Reference: FG1755). Services for accessing these data are
described at the back of the journal.
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Table 1
Selected geometric parameters (AÊ , ).
O3ÐC3 1.289 (2)
O5ÐC5 1.276 (2)
C1ÐC2 1.508 (3)
C1ÐC11 1.515 (2)
C2ÐC3 1.498 (2)
C3ÐC4 1.385 (2)
C4ÐC5 1.390 (2)
C5ÐC6 1.509 (2)
C6ÐC7 1.441 (3)
C7ÐC71 1.518 (2)
C1ÐC2ÐC3 116.56 (14)
O3ÐC3ÐC2 113.52 (14)
O3ÐC3ÐC4 121.12 (15)
C2ÐC3ÐC4 125.36 (15)
C3ÐC4ÐC5 120.71 (16)
O5ÐC5ÐC4 120.83 (15)
O5ÐC5ÐC6 117.67 (17)
C4ÐC5ÐC6 121.50 (17)
Table 2
Hydrogen-bonding geometry (AÊ , ).
Cg1 denotes the centroid of the C11±C16 ring and Cg2 the centroid of the
C71±C76 ring.
DÐH  A DÐH H  A D  A DÐH  A
O3ÐH3  O5 0.82 1.74 2.472 (2) 147
O5ÐH5  O3 0.82 1.75 2.472 (2) 146
O14ÐH14  O5i 0.82 2.18 2.934 (2) 153
O14ÐH14  O13 0.82 2.21 2.655 (2) 114
O74ÐH74  O3ii 0.82 2.14 2.773 (2) 134
O74ÐH74  O73 0.82 2.23 2.678 (2) 115
C7ÐH7A  O13iii 0.97 2.54 3.510 (3) 173
C12ÐH12  O74iv 0.93 2.51 3.411 (2) 162
C1ÐH1B  Cg1v 0.97 3.29 3.89 122
C2ÐH2A  Cg2vi 0.97 3.20 3.82 123
Symmetry codes: (i) x; y; zÿ 1; (ii) 1 x; 1 y; 1 z; (iii) x; y; 1 z; (iv) 2ÿ x;
1ÿ y; 1ÿ z; (v) 1ÿ x;1ÿ y; ÿz; (vi) 1ÿ x; 1ÿ y; 1ÿ z.
